Suppr超能文献

机器人辅助与腹腔镜根治性肾切除术围手术期结果的比较:一项系统评价和荟萃分析

Comparison of Perioperative Outcomes of Robot-Assisted vs. Laparoscopic Radical Nephrectomy: A Systematic Review and Meta-Analysis.

作者信息

Li Jinze, Peng Lei, Cao Dehong, Cheng Bo, Gou Haocheng, Li Yunxiang, Wei Qiang

机构信息

Department of Urology, Nanchong Central Hospital, The Second Clinical Medical College, North Sichuan Medical College, Nanchong, China.

Department of Urology, Institute of Urology, West China Hospital, Sichuan University, Chengdu, China.

出版信息

Front Oncol. 2020 Sep 18;10:551052. doi: 10.3389/fonc.2020.551052. eCollection 2020.

Abstract

The use of robot-assisted radical nephrectomy (RARN) for renal cell carcinoma (RCC) has increased in recent years, but the advantages of RARN over laparoscopic radical nephrectomy (LRN) remain controversial. This study aimed to compare the perioperative outcomes between RARN and LRN. We systematically searched the EMBASE, PubMed, Web of Science, and CNKI databases to identify eligible comparative studies. The parameters were perioperative outcomes including operating time (OT), estimated blood loss (EBL), length of stay (LOS), conversion rate, and complications. Stata 15.0 software was used for the meta-analysis. Seven studies with 1,832 patients were included in the analysis. Among them, 532 underwent RARN and 840 underwent LRN for RCC. There were no significant differences in OT (weighted mean difference [WMD], 29.05; 95% confidence interval [CI], -0.31, 58.41; = 0.05), EBL (WMD, -4.56; 95% CI, -29.79, 20.67; = 0.72), LOS (WMD, -0.34; 95% CI, -0.68, 0.00; = 0.05), conversion rate (WMD, 2.67; 95% CI, 0.68, 10.46; = 0.05), transfusion rate (odds ratio [OR], 1.30; 95% CI, 0.74, 2.27; = 0.36), intraoperative complications (OR, 1.13; 95% CI, 0.61, 2.12; = 0.62), and postoperative complications (OR, 1.07; 95% CI, 0.68, 1.67; = 0.62) between the two groups. RARN was not superior to LRN in patients with RCC in terms of perioperative outcomes. Before establishing conclusive clinical recommendations, high-quality prospective large-scale randomized controlled trials with long-term follow-up are needed.

摘要

近年来,机器人辅助根治性肾切除术(RARN)在肾细胞癌(RCC)治疗中的应用有所增加,但RARN相对于腹腔镜根治性肾切除术(LRN)的优势仍存在争议。本研究旨在比较RARN和LRN的围手术期结局。我们系统检索了EMBASE、PubMed、Web of Science和CNKI数据库,以确定符合条件的比较研究。观察指标为围手术期结局,包括手术时间(OT)、估计失血量(EBL)、住院时间(LOS)、中转率和并发症。采用Stata 15.0软件进行荟萃分析。分析纳入了7项研究,共1832例患者。其中,532例行RARN治疗RCC,840例行LRN治疗RCC。两组在OT(加权均数差[WMD],29.05;95%置信区间[CI],-0.31,58.41;P = 0.05)、EBL(WMD,-4.56;95% CI,-29.79,20.67;P = 0.72)、LOS(WMD,-0.34;95% CI,-0.68,0.00;P = 0.05)、中转率(WMD,2.67;95% CI,0.68,10.46;P = 0.05)、输血率(比值比[OR],1.30;95% CI,0.74,2.27;P = 0.36)、术中并发症(OR,1.13;95% CI,0.61,2.12;P = 0.62)及术后并发症(OR,1.07;95% CI,0.68,1.67;P = 0.62)方面均无显著差异。就围手术期结局而言,RARN在RCC患者中并不优于LRN。在确立确凿的临床建议之前,需要开展高质量的前瞻性大规模随机对照试验并进行长期随访。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/768e/7531174/5bd2d8326aa7/fonc-10-551052-g0001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验